CHO Stable Cell Line Development

Curia provides stable CHO cell line development services for diagnostic or therapeutic products.

Download this presentation detailing our CHO stable cell line development & process development services.

Developed from the CHO-K1 parental cell line, Curia offers the CHO-GSN℠ stable cell line expression platform for the production of proteins and antibodies. CHO-GSN℠ is a glutamine synthetase (GS) knockout cell line for the generation of a research cell bank (RCB) and future use as a manufacturing cell line for commercial products.

  • Royalty-free, no commercial milestone payments
  • CHO-K1 GS knockout with stronger GS selection, high titers
  • Generational stability >80 generations demonstrated
  • Established track record; multi-programs in clinical stages

As a service, RCBs are generated under the following workflow

After the RCB is developed, Curia offers characterization services, MCB generation, and process development service

 

Download this presentation detailing our CHO stable cell line development & process development services.

To learn about Curia GMP manufacturing for antibodies/proteins and mRNA, please click here.

Are you looking to accelerate your drug development program? If you would like to speak to a member of our expert team, please contact Curia here.